Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0000950170-25-043406·Vicapsys Life Sciences, Inc.
Schedule 13G ownership disclosure
VICAPSYS LIFE SCIENCES INC COM
Common Stock, $0.001 par value · CUSIP: 92560A106
Event date: 2020-04-20
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Wildcat Capital Management, LLC
Shares: 6,070,588 · Class: 18.8%
- Wildcat Partner Holdings, LP
Shares: 6,070,588 · Class: 18.8%
- Leonard A. Potter
Shares: 6,070,588 · Class: 18.8%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000950170-25-043406
- Form type
- SCHEDULE 13G
- Filer
- Vicapsys Life Sciences, Inc.
- CIK
- CIK 1468639
- Filed
- Mar 21, 2025
- Reporting period
- Apr 20, 2020
- Description
- Schedule 13G beneficial ownership